ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

RZLT Rezolute Inc

2.60
0.00 (0.00%)
Last Updated: 14:05:14
Delayed by 15 minutes

Period:

Draw Mode:

Volume 142,637
Bid Price 2.60
Ask Price 2.62
News -
Day High 2.7101

Low
0.72

52 Week Range

High
3.69

Day Low 2.535
Company Name Stock Ticker Symbol Market Type
Rezolute Inc RZLT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 2.60 14:05:14
Open Price Low Price High Price Close Price Prev Close
2.65 2.535 2.7101 2.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
853 142,637 $ 2.64 $ 376,565 - 0.72 - 3.69
Last Trade Time Type Quantity Stock Price Currency
14:05:14 100 $ 2.60 USD

Rezolute Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
101.84M 39.63M - 0 -51.79M -1.31 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Rezolute News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RZLT Message Board. Create One! See More Posts on RZLT Message Board See More Message Board Posts

Historical RZLT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.313.692.502.99481,587-0.71-21.45%
1 Month2.683.692.222.93326,911-0.08-2.99%
3 Months0.963.690.91992.07347,4851.64170.83%
6 Months1.033.690.721.75228,9571.57152.43%
1 Year2.053.690.721.72130,7770.5526.83%
3 Years6.7717.390.723.2894,262-4.17-61.60%
5 Years20.1421.200.723.3882,866-17.54-87.09%

Rezolute Description

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Your Recent History

Delayed Upgrade Clock